Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Stelitano

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular AgentsMatteo Mori, Giovanni Stelitano, Laurent R Chiarelli, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular AgentsRui Shi, Bin Wang, Giovanni Stelitano, et al.
Microbiologyopen|December 22, 2025
Uncovering Insights Into the Biology of Mycobacterium tuberculosis Using Genetic ToolsAlessandro Stamilla, Deborah Recchia, Giovanni Stelitano, et al.
Journal of Medicinal Chemistry|October 5, 2021
Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular AgentsDongguang Fan, Bin Wang, Giovanni Stelitano, et al.
ACS Omega|July 24, 2023
CanB, a Druggable Cellular Target in <i>Mycobacterium tuberculosis</i>Giulia Degiacomi, Beatrice Gianibbi, Deborah Recchia, et al.
Biomedicines|July 29, 2023
Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial ActivityDongguang Fan, Bin Wang, Giovanni Stelitano, et al.
European Journal of Medicinal Chemistry|March 14, 2022
Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agentGiulia Cazzaniga, Matteo Mori, Fiorella Meneghetti, et al.
European Journal of Medicinal Chemistry|December 1, 2023
Benzothiozinone derivatives with anti-tubercular Activity-Further side chain investigationXiaomei Wu, Wenxin Wang, Giovanni Stelitano, et al.
International Journal of Molecular Sciences|January 21, 2022
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the <i>Mycobacterium tuberculosis</i> DprE1 EnzymeJosé Manuel Ezquerra-Aznárez, Giulia Degiacomi, Henrich Gašparovič, et al.
Journal of Medicinal Chemistry|June 13, 2020
Shedding X-ray Light on the Role of Magnesium in the Activity of <i>Mycobacterium tuberculosis</i> Salicylate Synthase (MbtI) for Drug DesignMatteo Mori, Giovanni Stelitano, Arianna Gelain, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular AgentsMatteo Mori, Giovanni Stelitano, Laurent R Chiarelli, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular AgentsRui Shi, Bin Wang, Giovanni Stelitano, et al.
Microbiologyopen|December 22, 2025
Uncovering Insights Into the Biology of Mycobacterium tuberculosis Using Genetic ToolsAlessandro Stamilla, Deborah Recchia, Giovanni Stelitano, et al.
Journal of Medicinal Chemistry|October 5, 2021
Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular AgentsDongguang Fan, Bin Wang, Giovanni Stelitano, et al.
ACS Omega|July 24, 2023
CanB, a Druggable Cellular Target in <i>Mycobacterium tuberculosis</i>Giulia Degiacomi, Beatrice Gianibbi, Deborah Recchia, et al.
Biomedicines|July 29, 2023
Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial ActivityDongguang Fan, Bin Wang, Giovanni Stelitano, et al.
European Journal of Medicinal Chemistry|March 14, 2022
Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agentGiulia Cazzaniga, Matteo Mori, Fiorella Meneghetti, et al.
European Journal of Medicinal Chemistry|December 1, 2023
Benzothiozinone derivatives with anti-tubercular Activity-Further side chain investigationXiaomei Wu, Wenxin Wang, Giovanni Stelitano, et al.
International Journal of Molecular Sciences|January 21, 2022
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the <i>Mycobacterium tuberculosis</i> DprE1 EnzymeJosé Manuel Ezquerra-Aznárez, Giulia Degiacomi, Henrich Gašparovič, et al.
Journal of Medicinal Chemistry|June 13, 2020
Shedding X-ray Light on the Role of Magnesium in the Activity of <i>Mycobacterium tuberculosis</i> Salicylate Synthase (MbtI) for Drug DesignMatteo Mori, Giovanni Stelitano, Arianna Gelain, et al.
Pageof 4